Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of blood disorders and infectious diseases, increasing growth in POC hematology diagnostics product launches, and the paradigm shift from benchtop to portable hematology diagnostic systems.
The POC haematology diagnostics market is segmented as below:
By End-user
- Hospitals and clinics
- Homecare settings
- Clinical diagnostic laboratories
By Product
- Consumables
- Systems
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the POC haematology diagnostics market covers the following areas:
- POC haematology diagnostics market sizing
- POC haematology diagnostics market forecast
- POC haematology diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the global POC haematology diagnostics market: A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, Chengdu Seamaty Technology Co. Ltd., Danaher Corp., DIAGON Kft., Diamond Diagnostics Inc., Drucker Diagnostics LLC, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., HORIBA Ltd., Medsource Ozone Biomedicals Pvt. Ltd., Norma Instruments Zrt., Nova Biomedical Corp., PixCell Medical Technologies Ltd., S.D. Sight Diagnostics Ltd., Sekisui Diagnostics LLC, Mindray Bio medical Electronics Co. Ltd., Siemens AG, Sysmex Corp., and Transasia Bio Medicals Ltd..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is an increase in online marketing.'
According to the report, one of the major drivers for this market is the increasing prevalence of blood disorders and infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- A. Menarini Industrie Farmaceutiche Riunite Srl
- Abbott Laboratories
- Chengdu Seamaty Technology Co. Ltd.
- Danaher Corp.
- DIAGON Kft.
- Diamond Diagnostics Inc.
- Drucker Diagnostics LLC
- EKF Diagnostics Holdings Plc
- F. Hoffmann La Roche Ltd.
- HORIBA Ltd.
- Medsource Ozone Biomedicals Pvt. Ltd.
- Norma Instruments Zrt.
- Nova Biomedical Corp.
- PixCell Medical Technologies Ltd.
- S.D. Sight Diagnostics Ltd.
- Sekisui Diagnostics LLC
- Mindray Bio medical Electronics Co. Ltd.
- Siemens AG
- Sysmex Corp.
- Transasia Bio Medicals Ltd.